You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Abbott today announced the commencement of a cash tender offer for all outstanding shares of Alere's Series B convertible perpetual preferred stock.
The purchase of the preferred stock at $402 per share is in connection to Abbott's $5.3 billion acquisition of Alere. Alere shareholders approved the acquisition earlier this month.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.